Drugs / gammaglobulin
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT02540720 | Aug 2015 → Jul 2020 | immunoglobulin A vasculitis | Nanjing Children's Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT00001261 | May 1990 → Jul 2002 | dermatomyositis, inclusion body myositis | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
| Phase 2 | NCT00000520 | Jul 1985 → Nov 1989 | Kawasaki disease, coronary aneurysm | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00661401 | Jan → Nov 2002 | common variable immunodeficiency | Federal University of São Paulo | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| — | NCT03412188 Comparator | Aug 2018 → Sep 2021 | autoimmune thrombocytopenic purpura | Nayera Hazaa Elsherif | Completed | No outcome recorded |
| — | NCT01547143 Background | Mar 2012 → May 2016 | secondary hemophagocytic lymphohistiocytosis | Asan Medical Center | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gammaglobulin | “To test the efficacy of intravenous gamma globulin (IVGG) in preventing coronary artery aneurysms in children with Kawasaki Syndrome.” NCT00000520 ↗ |
| Known as | IVGG | “To test the efficacy of intravenous gamma globulin (IVGG) in preventing coronary artery aneurysms in children with Kawasaki Syndrome.” NCT00000520 ↗ |
| Modality | Protein / enzyme biologic | “intravenous gamma globulin” NCT00000520 ↗ |
| Route | Intravenous | “400 mg/kg/day of intravenous gamma globulin for four consecutive days plus aspirin as above.” NCT00000520 ↗ |